606 656
[11]
Langer R, Vacanti JP. Tissue engineering. Science 1993;260:920–6.
[12]
Place ES, Evans ND, Stevens MM. Complexity in biomaterials for tissue engineering. Nat Mater 2009;8:457–70.[13]
Ma PX. Biomimetic materials for tissue engineering. Adv Drug Deliv Rev 2008;60:184–98.
[14]
Freed LE, Vunjak-Novakovic G, Biron RJ, et al. Biodegradable poly- mer scaffolds for tissue engineering. Biotechnology NY 1994;12: 689–93.
[15]
Guo S, Dipietro LA. Factors affecting wound healing. J Dental Res 2010;89:219–29.
[16]
Bianco P, Robey PG. Stem cells in tissue engineering. Nature 2001;414:118–21.[17] Sloff M, de Vries R, Geutjes P, et al. Tissue engineering in animal
models for urinary diversion: a systematic review. PLoS One
2014;9:e98734
. http://dx.doi.org/10.1371/journal.pone.0105484 .[18]
Hooijmans CR, Tillema A, Leenaars M, Ritskes-Hoitinga M. Enhanc- ing search efficiency by means of a search filter for finding all studies on animal experimentation in PubMed. Lab Anim 2010;44:170–5.
[19]
de Vries RB, Hooijmans CR, Tillema A, Leenaars M, Ritskes-Hoitinga M. A search filter for increasing the retrieval of animal studies in Embase. Lab Anim 2011;45:268–70.
[20]
Akaike H. Akaike’s Information Criterion. In: Lovric M, editor. International Encyclopedia of Statistical Science. Berlin, Heidel- berg: Springer Berlin Heidelberg; 2011. p. 25.
[21]
Zou GY. Assessment of risks by predicting counterfactuals. Stat Med 2009;28:3761–81.[22]
Barbagli G, Sansalone S, Djinovic R, Romano G, Lazzeri M. Current controversies in reconstructive surgery of the anterior urethra: a clinical overview. Int Braz J Urol 2012;38:307–16, discussion 16.
[23]
Mundy AR, Andrich DE. Urethral strictures. BJU Int 2011;107:6–26.[24]
Subramaniam R, Spinoit AF, Hoebeke P. Hypospadias repair: an overview of the actual techniques. Semin Plast Surg 2011;25: 206–12.
[25] Singal AG, Higgins PD, Waljee AK. A primer on effectiveness and
efficacy trials. Clin Transl Gastroenterol 2014;5:e45.
http://dx.doi. org/10.1038/ctg.2013.13 .[26]
Faure A, Bouty A, Nyo YL, O’Brien M, Heloury Y. Two-stage graft urethroplasty for proximal and complicated hypospadias in chil- dren: a retrospective study. J Pediatr Urol 2016;12:286.
[27]
Sloff M, Simaioforidis V, de Vries R, Oosterwijk E, Feitz W. Tissue engineering of the bladder–reality or myth?. A systematic review. J Urol 2014;192:1035–42.[28]
Dorin RP, Pohl HG, De Filippo RE, Yoo JJ, Atala A. Tubularized urethral replacement with unseeded matrices: what is the maxi- mum distance for normal tissue regeneration? World J Urol 2008;26:323–6.
[29]
Qi N, Li WJ, Tian H. A systematic review of animal and clinical studies on the use of scaffolds for urethral repair. J Huazhong Univ Sci Technol Med Sci 2016;36:111–7.
[30]
Xue JD, Gao J, Fu Q, Feng C, Xie H. Seeding cell approach for tissue- engineered urethral reconstruction in animal study: a systematic review and meta-analysis. Exp Biol Med 2016;241:1416–28.
[31] Debels H, Hamdi M, Abberton K, Morrison W. Dermal matrices and
bioengineered skin substitutes: a critical review of current options.
Plast Reconstr Surg Glob Open 2015;3:e284.
http://dx.doi.org/10. 1097/GOX.0000000000000219 .[32]
de Vries RB, Buma P, Leenaars M, Ritskes-Hoitinga M, Gordijn B. Reducing the number of laboratory animals used in tissue engi- neering research by restricting the variety of animal models. Artic- ular cartilage tissue engineering as a case study. Tissue Eng Part B Rev 2012;18:427–35.
[33]
de Vries RB, Wever KE, Avey MT, et al. The usefulness of systematic reviews of animal experiments for the design of preclinical and clinical studies. ILAR J 2014;55:427–37.
[34]
Oerlemans AJ, Feitz WF, van Leeuwen E, Dekkers WJ. Regenerative urology clinical trials: an ethical assessment of road blocks and solutions. Tissue Engin Part B Rev 2013;19:41–7.[35]
Hooijmans CR, Leenaars M, Ritskes-Hoitinga M. A gold standard publication checklist to improve the quality of animal studies, to fully integrate the Three Rs, and to make systematic reviews more feasible. Altern Lab Anim 2010;38:167–82.
[36]
Dixit R, Boelsterli UA. Healthy animals and animal models of human disease(s) in safety assessment of human pharmaceuticals, includ- ing therapeutic antibodies. Drug Discov Today 2007;12:336–42.
[37]
Korevaar DA, Hooft L, ter Riet G. Systematic reviews and meta- analyses of preclinical studies: publication bias in laboratory ani- mal experiments. Lab Anim 2011;45:225–30.
[38]
Schneider CK, Salmikangas P, Jilma B, et al. Challenges with ad- vanced therapy medicinal products and how to meet them. Nat Rev Drug Discov 2010;9:195–201.[39] EMA. Regulation (EC) No 1394/2007 of the European Parliament
and of the Council on advanced therapy medicinal products and
amending Directive 2001/83/EC and Regulation (EC) No 726/2004.
2007.
[40]
Brevignon-Dodin L, Singh P. ATMP in practice: towards a new industry landscape in tissue engineering. J Commerc Biotechnol 2009;15:59–65.
[41]
Culme-Seymour EJ, Mason K, Vallejo-Torres L, et al. Cost of stem cell-based tissue-engineered airway transplants in the United Kingdom: case series. Tissue Eng Part A 2016;22:208–13.
[42]
Zhang Y, McNeill E, Tian H, et al. Urine derived cells are a potential source for urological tissue reconstruction. J Urol 2008;180: 2226–33.
E U R O P E A N U R O L O G Y 7 2 ( 2 0 1 7 ) 5 9 4 – 6 0 6
606